 |
(Natural News) Spanish researchers found new hope for patients with cognitive disorders like Down syndrome. Their experiment on cognitively-impaired mice revealed a link between Down syndrome and the endocannabinoid system. Furthermore, they identified cannabinoid receptor type-1 (CB1R) as a possible target for the treatment of Down syndrome. Mental disability stems from many causes, including genetic problems. The most... |
Promising new research suggests targeting the endocannabinoid system to treat cognitive disorders
Continue Reading
Bagikan Berita Ini
Related Posts :
The Internet crackdown begins: U.S. Senator Al Franken wants Google, Facebook and Twitter to censor political speech- Elderly heart patients have something new to worry about: Winter weather has been found to increase risk of death
- The top 10 rules for the next generation of liberty movement leaders (part 3 of 4)
- See what these three doctors believe should be done for kids who think they’re transgender
- Yet another highly effective herb for sore throats: Icelandic moss is full of nutrients and has been used for eons
0 Response to "Promising new research suggests targeting the endocannabinoid system to treat cognitive disorders"
Post a Comment